Topsalysin
N/A
Report date: 2024/04/05 20:04:39
Base Information
Drug NameTopsalysin
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSophiris Bio Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSophiris Bio CorpKissei Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A